Minimum Program Requirements for Non-Residential Opioid Treatment Program Facilities

First Page		Document Content
Date: 2013-01-09 10:29:10 Morphinans Neurochemistry Euphoriants Substance dependence Ketones Methadone Buprenorphine Opioid dependence Opioid agonist treatment Chemistry Organic chemistry Drug rehabilitation		Minimum Program Requirements for Non-Residential Opioid Treatment Program Facilities Add to Reading List Source URL: www.state.tn.us Download Document from Source Website File Size: 131,62 KB Share Document on Facebook

	Microsoft Word - VLD Packet.FINAL DocID: 1rubZ - View Document
	Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa DocID: 1rtjz - View Document
	TITAN PHARMACEUTICALS CORPORATE PRESENTATION SUNIL BHONSLE JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. NASDAQ:TTNP DocID: 1rsmr - View Document
	Sunil Bhonsle Mar 2015 Corporate Presentation DocID: 1rrwl - View Document
	Adapt v13_doc revised DocID: 1rrqr - View Document